Effects of testosterone replacement on sexual behavior in hypogonadal men. 1982

P Salmimies, and G Kockott, and K M Pirke, and H J Vogt, and W B Schill

Fifteen patients with hypogonadism due to testicular, pituitary, or hypothalamic failure were studied. After a pretreatment period without substitution, patients received intramuscular injections of testosterone enanthate, equivalent to 25, 50, 100, and 250 mg testosterone, or placebo. Each dose was given for 4 weeks, with injections given every 2 weeks. All patients with plasma testosterone values below 2 ng/ml during the pretreatment period reported impaired sexual function. They responded to testosterone injections (50, 100, and 250 mg) with improvement of sexual behavior, as rated by sexual desire and frequency of erections and ejaculations. In the range between 2.0 and 4.5 ng testosterone per ml, four patients reported high frequencies of erections and ejaculations that did not change after testosterone treatment. Four other patients with testosterone values in the same range reported impaired sexual behavior and were successfully treated with testosterone enanthate. These data indicate that male sexual behavior is testosterone dependent and that the individual limit of plasma testosterone below which sexual behavior is impaired lies between 2.0 and 4.5 ng/ml.

UI MeSH Term Description Entries
D007006 Hypogonadism Condition resulting from deficient gonadal functions, such as GAMETOGENESIS and the production of GONADAL STEROID HORMONES. It is characterized by delay in GROWTH, germ cell maturation, and development of secondary sex characteristics. Hypogonadism can be due to a deficiency of GONADOTROPINS (hypogonadotropic hypogonadism) or due to primary gonadal failure (hypergonadotropic hypogonadism). Hypergonadotropic Hypogonadism,Hypogonadism, Isolated Hypogonadotropic,Hypogonadotropic Hypogonadism,Hypogonadism, Hypergonadotropic,Hypogonadism, Hypogonadotropic
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D007989 Libido The psychic drive or energy associated with sexual instinct in the broad sense (pleasure and love-object seeking). It may also connote the psychic energy associated with instincts in general that motivate behavior. Decreased Libido,Increased Libido,Libido, Decreased,Libido, Increased
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010413 Penis The external reproductive organ of males. It is composed of a mass of erectile tissue enclosed in three cylindrical fibrous compartments. Two of the three compartments, the corpus cavernosa, are placed side-by-side along the upper part of the organ. The third compartment below, the corpus spongiosum, houses the urethra. Glans Penis,Penis, Glans
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004542 Ejaculation The emission of SEMEN to the exterior, resulting from the contraction of muscles surrounding the male internal urogenital ducts. Ejaculations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

P Salmimies, and G Kockott, and K M Pirke, and H J Vogt, and W B Schill
August 2000, The Journal of clinical endocrinology and metabolism,
P Salmimies, and G Kockott, and K M Pirke, and H J Vogt, and W B Schill
February 2024, The world journal of men's health,
P Salmimies, and G Kockott, and K M Pirke, and H J Vogt, and W B Schill
June 1979, The Journal of clinical endocrinology and metabolism,
P Salmimies, and G Kockott, and K M Pirke, and H J Vogt, and W B Schill
March 2022, Endocrinology and metabolism clinics of North America,
P Salmimies, and G Kockott, and K M Pirke, and H J Vogt, and W B Schill
August 2015, Current urology reports,
P Salmimies, and G Kockott, and K M Pirke, and H J Vogt, and W B Schill
January 2024, The Journal of clinical endocrinology and metabolism,
P Salmimies, and G Kockott, and K M Pirke, and H J Vogt, and W B Schill
January 2015, Best practice & research. Clinical endocrinology & metabolism,
P Salmimies, and G Kockott, and K M Pirke, and H J Vogt, and W B Schill
October 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
P Salmimies, and G Kockott, and K M Pirke, and H J Vogt, and W B Schill
June 1985, Clinical endocrinology,
P Salmimies, and G Kockott, and K M Pirke, and H J Vogt, and W B Schill
September 2003, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!